QDEL Stock Overview
Provides diagnostic testing solutions. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
QuidelOrtho Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$36.18 |
| 52 Week High | US$75.86 |
| 52 Week Low | US$29.74 |
| Beta | 0.12 |
| 11 Month Change | -11.39% |
| 3 Month Change | -19.51% |
| 1 Year Change | -45.39% |
| 33 Year Change | -76.28% |
| 5 Year Change | -45.41% |
| Change since IPO | 112.82% |
Recent News & Updates
Recent updates
QuidelOrtho (NASDAQ:QDEL) Seems To Be Using A Lot Of Debt
Sep 15
QuidelOrtho Corporation (NASDAQ:QDEL) Stock Catapults 38% Though Its Price And Business Still Lag The Industry
Aug 09QuidelOrtho: Attractive Valuation Despite Weak Performance
Apr 13We Think QuidelOrtho (NASDAQ:QDEL) Is Taking Some Risk With Its Debt
Apr 08QuidelOrtho Corporation's (NASDAQ:QDEL) 38% Dip In Price Shows Sentiment Is Matching Revenues
Feb 15QuidelOrtho Corporation (NASDAQ:QDEL) Shares Could Be 38% Below Their Intrinsic Value Estimate
Mar 13QuidelOrtho Corporation Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Feb 18An Intrinsic Calculation For QuidelOrtho Corporation (NASDAQ:QDEL) Suggests It's 47% Undervalued
Nov 25QuidelOrtho forecasts strong Q3 revenue above estimates, shares rise ~6% after hours
Oct 12QuidelOrtho: Fundamentals Remain, Upbeat Financials
Sep 14Improved Earnings Required Before QuidelOrtho Corporation (NASDAQ:QDEL) Shares Find Their Feet
Sep 03QuidelOrtho announces $300M share repurchase authorization
Aug 17Robust Earnings May Not Tell The Whole Story For QuidelOrtho (NASDAQ:QDEL)
Aug 13Quidel Non-GAAP EPS of $2.34 misses by $0.51, revenue of $613.4M misses by $27.21M
Aug 04QuidelOrtho: Continuing Its Upward Ascent
Jul 08Shareholder Returns
| QDEL | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -17.3% | -1.1% | -2.1% |
| 1Y | -45.4% | 22.8% | 30.2% |
Return vs Industry: QDEL underperformed the US Medical Equipment industry which returned 22.8% over the past year.
Return vs Market: QDEL underperformed the US Market which returned 30.2% over the past year.
Price Volatility
| QDEL volatility | |
|---|---|
| QDEL Average Weekly Movement | 6.5% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: QDEL has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: QDEL's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 7,100 | Brian Blaser | www.quidelortho.com |
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions.
QuidelOrtho Corporation Fundamentals Summary
| QDEL fundamental statistics | |
|---|---|
| Market cap | US$2.43b |
| Earnings (TTM) | -US$1.87b |
| Revenue (TTM) | US$2.82b |
0.9x
P/S Ratio-1.3x
P/E RatioIs QDEL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QDEL income statement (TTM) | |
|---|---|
| Revenue | US$2.82b |
| Cost of Revenue | US$1.48b |
| Gross Profit | US$1.34b |
| Other Expenses | US$3.21b |
| Earnings | -US$1.87b |
Last Reported Earnings
Sep 29, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -27.75 |
| Gross Margin | 47.57% |
| Net Profit Margin | -66.25% |
| Debt/Equity Ratio | 80.5% |
How did QDEL perform over the long term?
See historical performance and comparison